Our latest updates regarding Coronavirus Disease
Dermatology Associates is tentatively set to gradually resume daily in-office operations effective May 11th 2020.
We continue to advise all patients to arrange a telehealth appointment if at all possible. Please contact our office (540) 667-4499 and we will answer your questions.
At this time, in alignment with the American Academy of Dermatology, we are using telemedicine to support as many patients as possible. This includes some exams, follow-up visits and patients with the conditions listed below.
For essential, urgent, or significant cases, for evaluation, call our office to arrange an in-person visit as needed.
Any new patients will be screened via our telemedicine process. Please call our office to schedule an appointment.
We appreciate all of our cosmetics patients understanding as we have placed elective cosmetic procedures on hold due to COVID-19.
With the practice gradual reopening May 11th 2020, Dr. Stephen Flax, our Board Certified Dermatologist will continue to provide aesthetic nonsurgical procedures for those patients interested in facial enhancement through the use of Botox and fillers.
We will continue to monitor data and when deemed safe will announce Botox days and open his schedule for filler patients. Our practice will continue to sell cosmetic products, but at this time products are limited and will be ordered based on demand.
Patients needing refills for cosmetic prescriptions will still need to be seen by appointment and Rxs will be sent to the pharmacy as our practice will no longer sell in house.
Telemedicine and Insurance
We will be maintaining in-office visits for the following patients:
high-risk: those with multiple melanomas, SCC, and transplant patients
those with painful inflamed cysts
surgeries: SCC (Squamous Cell Carcinoma) and melanoma (high-risk)
those with new-onset rashes
those with melanoma follow-up
acne flare-ups and follow up
Accutane (isotretinoin follow up for males and females)
new lesions of concern
other consultations and appointments
For the following types of appointments, we will be scheduling visits at a later date:
surgeries for cysts, moles and BCC
other benign skin conditions
At this point in time, Dermatology Associates will be collecting all co-pays
until further notice. Telemedicine services are covered by most major
insurance companies. Please contact your insurance provider to verify.
How To Use Telemedicine Services
Telemedicine is a process where we can facilitate health services including medical advice, provider and patient education, health information services, and self-care support via digital communication.
Social Distancing: Updated Procedure For All In-Person Appointments
To ensure the safety of our patients and staff, please note our current procedure for facilitating appointments while limiting exposure to other individuals:
We will call you a day before your appointment.
When you arrive to Dermatology Associates for your appointment, drive in and park for your appointment.
Upon arrival, call in to let us know you've arrived:
Amherst location: (540) 667-0500
Cedar Creek Grade: (540) 486-4399
Front Royal: (540) 486-4398
When you call, if there is no one in the waiting room, we'll have you come in long enough to fill out your paperwork and head to your appointment. If there are already 2 people in the waiting room, we'll ask you to remain in your car and we'll call you when it's time for your appointment.
Patients on Biologics: Should I Continue Treatment?
Due to the recent pandemic, there is concern about the immunomodulatory effects of biologic therapy in the context of coronavirus (COVID-19). With COVID-19 having the biggest impact on older patients and those with suppressed immune systems, you may wonder if continuing biologic treatment is a good idea. Currently, there is no data on the specific risk of COVID-19 infection with biologic therapy. Specifically, we do not have direct evidence to support any preferred biologic class or mechanism-of-action with regard to COVID-19 infection risk at this moment; although we will continue to monitor the situation as more data become available.
You are receiving biologic treatment if you are taking one of the following medications listed below.
Biologic medications include:
Cimzia, Cosentyx, Enbrel, Humira, Ilumya, Siliq, Simponi, Skyrizi, Stelara, Taltz, and Tremfya
Patients participating in the Psoriasis Study can continue to participate in the study even if you are seen through telemedicine venue.
For patients on biologic therapy who have not tested positive or exhibited signs/symptoms of COVID-19: There is insufficient evidence to recommend discontinuation of biologics at this time.
Please make a decision about your treatments taking this into account and acting responsibly for your personal health and those of others.
Potential Disruptions to Our Regular Schedule
Depending on community trends with COVID-19, offices may reduce patient load or close with short notice.
We will notify you if it is necessary to temporarily close an office. Please visit this page for regular updates.